Ernest Mario
Chairman chez SOLENO THERAPEUTICS, INC.
Fortune : 10 M $ au 31/03/2024
Profil
Ernest Mario is currently the Chief Executive Officer at ALZA Pharmaceuticals.
He is also the Chairman at Soleno Therapeutics, Inc., American Foundation for Pharmaceutical Education, Orbus Therapeutics, Inc., Capnia, Inc., and TAXIS Pharmaceuticals, Inc. Additionally, he serves as a Director at Rutgers University Foundation, Gladstone Foundation (CA), Silver Bullet Therapeutics, Inc., and Metalmark Capital LLC.
Dr. Mario was previously the Chairman & Chief Executive Officer at ALZA Corp., Glaxo Wellcome Plc, IntraBiotics Pharmaceuticals, Inc., Reliant Pharmaceuticals LLC, and Apothogen, Inc. He also held positions as the Deputy Chairman & Chief Executive Officer at Glaxo Holdings Plc and Chief Executive Officer at GlaxoSmithKline Services Unlimited.
Dr. Mario has served as the Chairman at Chimerix, Inc. and Duke University Health System, Inc. He was an Independent Director at Celgene Corp.
and Boston Scientific Corp.
Dr. Mario has also been the Lead Independent Director at Pharmaceutical Product Development LLC and an Independent Director at VIVUS, Inc., Maxygen, Inc., Alexza Pharmaceuticals, Inc., Prestwick Pharmaceuticals, Inc., Avid Radiopharmaceuticals, Inc., TARIS BioMedical LLC, Delpor, Inc., Tonix Pharmaceuticals, Inc., Kindred Biosciences, Inc., XenoPort, Inc., Eyenovia, Inc., and Amplitude Healthcare Acquisition Corp.
He served as a Director at Celgene, Inc. Dr. Mario has held trustee positions at Duke University, the University of Rhode Island, and Rutgers State University of New Jersey.
He is also an Executive Advisory Board Member at Linden Manager LLC and a Board Member at Catalytica, Inc. Dr. Mario received his graduate and doctorate degrees from the University of Rhode Island and his undergraduate degree from Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0,70% | 08/01/2024 | 228 071 ( 0,70% ) | 10 M $ | 31/03/2024 |
Postes actifs de Ernest Mario
| Sociétés | Poste | Début |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Chairman | 03/08/2007 |
| Gladstone Foundation (CA) | Director/Board Member | - |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Chairman | 01/08/2015 |
TAXIS Pharmaceuticals, Inc.
 TAXIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ. | Director/Board Member | - |
| Silver Bullet Therapeutics, Inc. | Director/Board Member | - |
| ALZA Pharmaceuticals | Chief Executive Officer | - |
Capnia, Inc.
 Capnia, Inc. Medical SpecialtiesHealth Technology Capnia, Inc. develops diagnostics and devices to address unmet medical needs. Its CoSense® End-Tidal Carbon Monoxide Monitor product measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. The company is headquartered in Foster City, CA. | Chairman | - |
Metalmark Capital LLC
 Metalmark Capital LLC Investment ManagersFinance Metalmark Capital LLC (Metalmark Capital) is a private equity firm founded by John J. Moon in 1986. The firm is headquartered in New York. | Consultant / Advisor | - |
| American Foundation for Pharmaceutical Education | Chairman | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Ernest Mario
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Ernest Mario
| University of Rhode Island | Doctorate Degree |
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Distribution Services |
| CHIMERIX, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| EYENOVIA, INC. | Health Technology |
| Entreprise privées | 36 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
Metalmark Capital LLC
Metalmark Capital LLC Investment ManagersFinance Metalmark Capital LLC (Metalmark Capital) is a private equity firm founded by John J. Moon in 1986. The firm is headquartered in New York. | Finance |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
Avid Radiopharmaceuticals, Inc.
 Avid Radiopharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA. | Health Services |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
TAXIS Pharmaceuticals, Inc.
TAXIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Delpor, Inc.
 Delpor, Inc. Pharmaceuticals: MajorHealth Technology Delpor, Inc. develops therapeutic products. Its products include DLP-114, DLP-119, DLP-202 and DLP-414. The company was founded by Tassos Nicolaou and Frank Martin in 2009 and is headquartered in San Francisco, CA. | Health Technology |
Tonix Pharmaceuticals, Inc.
 Tonix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TONIX Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Seth Lederman and Daniel L. Kreisler on June 7, 2007 and is headquartered in New York, NY. | Health Technology |
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. | Health Technology |
Duke University Health System, Inc.
 Duke University Health System, Inc. Medical/Nursing ServicesHealth Services Duke University Health System, Inc. engages in the provision of health care services. It offers cancer treatment, primary care, orthopedics, aesthetics, and fertility services. The company was founded in 1998 and is headquartered in Durham, NC. | Health Services |
Apothogen, Inc.
 Apothogen, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Apothogen, Inc. is a private company that develops and markets pharmaceuticals. The company is based in Raleigh, NC. Apothogen was acquired by IntraBiotics Pharmaceuticals, Inc. on April 24, 2002 for $1.81 million. | Health Technology |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Linden Manager LLC
 Linden Manager LLC Investment ManagersFinance Linden Manager LLC (Linden Capital Partners) is a private equity firm founded in 2004 by Anthony B Davis and Brain C Miller. The firm is headquartered in Chicago, Illinois. | Finance |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
| American Foundation for Pharmaceutical Education | Miscellaneous |
| ALZA Pharmaceuticals | |
| Glaxo Holdings Plc | Finance |
Rutgers University Foundation
 Rutgers University Foundation Investment Trusts/Mutual FundsMiscellaneous Rutgers University Foundation is the fundraising arm of Rutgers University. The foundation build relationships with alumni and friends, corporations, and foundations and seek their support of Rutgers programs throughout New Jersey and the world. It was founded in 1973 and it is headquartered in New Brunswick, NJ. | Miscellaneous |
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Celgene, Inc.
 Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Health Technology |
| Catalytica, Inc. | Health Technology |
| Gladstone Foundation (CA) | |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
Amplitude Healthcare Acquisition Corp.
 Amplitude Healthcare Acquisition Corp. Financial ConglomeratesFinance Amplitude Healthcare Acquisition Corp. operates as a blank check company. It aims to acquire one or more businesses and assets through a merger, share purchase and reorganization. The company was founded on August 13, 2019 and is headquartered in New York, NY. | Finance |
Capnia, Inc.
Capnia, Inc. Medical SpecialtiesHealth Technology Capnia, Inc. develops diagnostics and devices to address unmet medical needs. Its CoSense® End-Tidal Carbon Monoxide Monitor product measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. The company is headquartered in Foster City, CA. | Health Technology |
| Silver Bullet Therapeutics, Inc. |
